Study summary · research use only
Acetyl-L-carnitine in chronic pain: A narrative review
Plain-language summary
Paraphrased from the published abstract below — not a verdict on whether anything works.
This narrative review summarizes evidence on acetyl-L-carnitine (ALC), an endogenous molecule involved in energy metabolism with antioxidant properties, in chronic pain. Species is not specified, as the review spans experimental and clinical literature. The authors describe ALC as modulating brain neurotransmitters including acetylcholine, serotonin, and dopamine, and acting on neurotrophic factors such as nerve growth factor (NGF) and metabotropic glutamate (mGlu) receptors via epigenetic mechanisms, including induction of mGlu2 expression at nerve terminals, which they associate with analgesia and prevention of spinal sensitisation. They note experimental models of chronic inflammatory and neuropathic pain have reported long-term neurotrophic and analgesic activity for ALC. The review examines the rationale for ALC use in fibromyalgia syndrome, characterized by nociplastic changes increasing nervous system pain sensitivity.
Abstract
Acetyl-L-carnitine (ALC) is an endogenous molecule that not only plays a role in energy metabolism, but also has antioxidant properties, protects from oxidative stress, modulates brain neurotransmitters such as acetylcholine, serotonin and dopamine, and acts on neurotrophic factors such as nerve growth factor (NGF) and metabotropic glutamate (mGlu) receptors by means of epigenetic mechanisms. Importantly, it induces mGlu2 expression at nerve terminals, thus giving rise to analgesia and preventing spinal sensitisation. It has also been found to have even long-term neurotrophic and analgesic activity in experimental models of chronic inflammatory and neuropathic pain. The aim of this narrative review is to summarise the current evidence regarding the use of ALC in patients with chronic pain, and cognitive and mood disorders, and investigate the rationale underlying its use in patients with fibromyalgia syndrome, which is characterised by nociplastic changes that increase the sensitivity of the nervous system to pain.
pepmg summarizes the peer-reviewed literature and links to every source — it sells nothing, ships nothing, and gives no medical, dosing, or human-use guidance. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.